GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » AirSculpt Technologies Inc (NAS:AIRS) » Definitions » Debt-to-EBITDA

AirSculpt Technologies (AirSculpt Technologies) Debt-to-EBITDA : 1.79 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is AirSculpt Technologies Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

AirSculpt Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $8.2 Mil. AirSculpt Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $90.6 Mil. AirSculpt Technologies's annualized EBITDA for the quarter that ended in Mar. 2024 was $55.3 Mil. AirSculpt Technologies's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 1.79.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for AirSculpt Technologies's Debt-to-EBITDA or its related term are showing as below:

AIRS' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 3.18   Med: 5.05   Max: 30.62
Current: 3.36

During the past 5 years, the highest Debt-to-EBITDA Ratio of AirSculpt Technologies was 30.62. The lowest was 3.18. And the median was 5.05.

AIRS's Debt-to-EBITDA is ranked worse than
58.49% of 424 companies
in the Healthcare Providers & Services industry
Industry Median: 2.645 vs AIRS: 3.36

AirSculpt Technologies Debt-to-EBITDA Historical Data

The historical data trend for AirSculpt Technologies's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AirSculpt Technologies Debt-to-EBITDA Chart

AirSculpt Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
8.02 3.18 4.50 30.62 5.05

AirSculpt Technologies Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.92 3.57 7.04 5.96 1.79

Competitive Comparison of AirSculpt Technologies's Debt-to-EBITDA

For the Medical Care Facilities subindustry, AirSculpt Technologies's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AirSculpt Technologies's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, AirSculpt Technologies's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where AirSculpt Technologies's Debt-to-EBITDA falls into.



AirSculpt Technologies Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

AirSculpt Technologies's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(7.5 + 92.168) / 19.736
=5.05

AirSculpt Technologies's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(8.249 + 90.618) / 55.268
=1.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


AirSculpt Technologies  (NAS:AIRS) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


AirSculpt Technologies Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of AirSculpt Technologies's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


AirSculpt Technologies (AirSculpt Technologies) Business Description

Traded in Other Exchanges
N/A
Address
1111 Lincoln Road, Suite 802, Miami Beach, FL, USA, 33139
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under our brand Elite Body Sculpture. At Elite Body Sculpture, company provide custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. Its mission is to generate the best results for patients.
Executives
Todd Magazine director, officer: President and CEO 1111 LINCOLN ROAD, SUITE 802, MIAMI BEACH FL 33139
Thomas J Aaron director 4000 MERIDIAN BOULEVARD, FRANKLIN TN 37067
Dennis Dean officer: Chief Financial Officer 40 BURTON HILLS BOULEVARD SUITE 500, NASHVILLE TN 37215
Caroline Chu director 400 ALTON ROAD, UNIT TH-103M, MIAMI BEACH FL 33139
Kenneth Higgins director 400 ALTON ROAD, UNIT TH-103M, MIAMI BEACH FL 33139
Aaron Rollins director, 10 percent owner, officer: Chief Executive Officer 400 ALTON ROAD, UNIT TH-103M, MIAMI BEACH FL 33139
Adam T Feinstein director, 10 percent owner 40 BURTON HILLS BOULEVARD SUITE 500, NASHVILLE TN 37215
Ronald P. Zelhof officer: COO and President 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Pamela L. Netzky director C/O AMPLIFY SNACK BRANDS, INC., 500 WEST 5TH STREET, AUSTIN TX 78701
Daniel Sollof director 400 ALTON ROAD, UNIT TH-103M, MIAMI BEACH FL 33139
Vscp Ebs Aggregator, L.p. director, 10 percent owner 428 GREENWICH STREET, NEW YORK NY 10013
Ebs Aggregator Blocker Holdings, Llc director, 10 percent owner 428 GREENWICH STREET, NEW YORK NY 10013